ABSTRACT
INTRODUCTION (1):
Ranolazine is -(2,6-dimethylphenyl)-2{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl piprazine-1-yl}acetamide is piprazine derivative appears as white to off white crystalline powder. The drug is freely soluble in Methanol. Ranolazine is a strong base with pKa values of 13.6(2), Six-membered Piprazine Ring. Edaravone melts at 122-124 ⁰C(3). 
Mechanism of Action (4,5)
Ranolazine a piperazine derivative is a new anti-ischemic drug for the treatment of angina. Ranolazine is to inhibit late I Na thus preventing sodium overload of the cell. As a consequence, ranolazine prevents reverse mode sodiumcalcium exchange and thus diastolic accumulation of calcium possibly resulting in improved diastolic tone and improved coronary blood flow. As a late I Na inhibitor, ranolazine was also shown to increase action potential duration and thus modestly QT interval by 2-5 ms. This effect, however, is not heart rate-dependent and cannot be exaggerated during bradycardia. Furthermore, ranolazine does not induce early after depolarization and does not increase dispersion of repolarization across the left ventricular wall. (4) It is act via selective inhibition of the late inward sodium current (I Na ) in cardiac muscle cells. This reduces intracellular sodium accumulation and calcium overload, and consequently improves myocardial relaxation and decreases left ventricular diastolic stiffness. (5) Ranolazine is administered orally and metabolize by CYP3A and excreted in intestine (5%) and in urine.
Combination of Ranolazine(6) Ranolazine+Dronederone
Marketed formulation of Ranolazine(7) Ranexa, Caroza, Rolazine 
II. UV spectroscopic method
First order derivative spectroscopy and Area Under curve spectroscopic technique was developed for simultaneous determination of Ranolazine. Colorimetry and Visible spectroscopy was developed for estimation of Ranolazine. 
DISCUSSION
Presented systematic review covers the current analytical methods for the determination of Ranolazine and its combination in pharmaceutical and biological samples like serum and plasma. HPLC method were found to be most widely use for Ranolazine. Various chromatographic conditions are presented in table.
CONCLUSION
The sensitivity, specificity, and better separation efficiency enable HPLC to be used frequently for simultaneous qualitative and quantitative determination of Ranolazine. The presented information is useful for the future study for researcher involved in formulation development and quality control of Ranolazine.
